(Q61922161)
Statements
A Phase 2 Multicenter, Randomized, Placebo- and Comparator-Controlled, Double-Blind Parallel Group Study to Evaluate the Safety and Efficacy of Topical NEOSH101 in the Treatment of Androgenetic Alopecia in Men (English)
0 references
January 2007
0 references
October 2007
0 references
180
0 references
18 year
0 references
49 year
0 references